908 results
Search Results
2. A novel agonist of 4-1BB costimulatory receptor shows therapeutic efficacy against a tobacco carcinogen-induced lung cancer.
- Author
-
Gulen, Ayse Ece, Rudraboina, Rakesh, Tarique, Mohammad, Ulker, Vahap, Shirwan, Haval, and Yolcu, Esma S.
- Subjects
LUNG cancer ,TREATMENT effectiveness ,KILLER cells ,IMMUNE checkpoint inhibitors ,IMMUNE checkpoint proteins ,STREPTAVIDIN ,PROSTATE cancer ,PROSTATE-specific antigen - Abstract
Immunotherapy utilizing checkpoint inhibitors has shown remarkable success in the treatment of cancers. In addition to immune checkpoint inhibitors, immune co-stimulation has the potential to enhance immune activation and destabilize the immunosuppressive tumor microenvironment. CD137, also known as 4-1BB, is one of the potent immune costimulatory receptors that could be targeted for effective immune co-stimulation. The interaction of the 4-1BB receptor with its natural ligand (4-1BBL) generates a strong costimulatory signal for T cell proliferation and survival. 4-1BBL lacks costimulatory activity in soluble form. To obtain co-stimulatory activity in soluble form, a recombinant 4-1BBL protein was generated by fusing the extracellular domains of murine 4-1BBL to a modified version of streptavidin (SA-4-1BBL). Treatment with SA-4-1BBL inhibited the development of lung tumors in A/J mice induced by weekly injections of the tobacco carcinogen NNK for eight weeks. The inhibition was dependent on the presence of T cells and NK cells; depletion of these cells diminished the SA-4-1BBL antitumor protective effect. The number of lung tumor nodules was significantly reduced by the administration of SA-4-1BBL to mice during ongoing exposure to NNK. The data presented in this paper suggest that utilizing an immune checkpoint stimulator as a single agent generate a protective immune response against lung cancer in the presence of a carcinogen. More broadly, this study suggests that immune checkpoint stimulation can be extended to a number of other cancer types, including breast and prostate cancers, for which improved diagnostics can detect disease at the preneoplastic stage. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
3. Terminological discrepancies and novelties in the histological description of the female genital system: proposed amendments for clinical-translational anatomy.
- Author
-
Varga, Ivan, Hammer, Niels, Pavlíková, Lada, Poilliot, Amelie, Klein, Martin, and Mikušová, Renáta
- Subjects
- *
GENITALIA , *OVARIAN follicle , *KILLER cells , *CYTOLOGY , *CLINICAL medicine - Abstract
Histological terminology of the female genital organs is currently a part of the internationally accepted nomenclature Terminologia Histologica (TH), the latest edition of which dates back to 2008. Many new discoveries have been documented within 16 years since then, and many discrepancies have been found. This paper aims to revise the terminology from clinical and educational perspectives comprehensively. The authors thoroughly searched the current edition of "Terminologia Histologica: International Terms for Human Cytology and Histology," focusing on missing and controversial terms in the chapter Female genital system. The authors identified six controversial and ambiguous terms and four missing important histological terms. The authors also discussed the addition of less used eponymic terms in the histological description of female genital organs like Hamperl cells, Popescu cells, Kroemer lacunae, Balbiani bodies, Call–Exner bodies, membrane of Slavianski, nabothian cysts, or anogenital sweat glands of van der Putte. We expect the second and revised edition of the TH to be published soon and hope that the Federative International Program on Anatomical Terminology will approve and incorporate all these propositions and suggestions. We also strongly recommend using the official internationally accepted Latin and English histological nomenclature—the TH, either in oral or written form, both in theoretical and clinical medicine. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Murine myeloid derived suppressor cells possess a range of suppressive mechanisms—Granzyme B is not among them.
- Author
-
Tibbs, Ellis and Cao, Xuefang
- Subjects
MYELOID-derived suppressor cells ,KILLER cells ,CYTOTOXIC T cells ,GRANZYMES ,BONE marrow cells - Abstract
This paper addresses the controversy of Granzyme B (GzmB) expression by murine Myeloid Derived Suppressor Cells (MDSCs). MDSCs are a heterogenous immature myeloid population that are generated in chronic inflammatory pathologies for the purpose to suppress inflammatory responses. MDSCs express a multitude of factors to induce suppressive function such as PD-L1, reactive oxygen species (ROS), nitric oxide synthase (iNOS), and Arginase-1. Recently, Dufait et al. sought to demonstrate GzmB as an additional mechanism for suppression by MDSCs. They reported that murine MDSCs not only significantly express GzmB as well as Perforin (Prf1), but this expression is functionally important for tumor growth in vivo as well as tumor migration in vitro. We conducted experiments to address the same question but made confounding observations: MDSCs under stringent developmental process do not express GzmB. Our results show that not only GzmB protein is not produced at functional level, but the mRNA transcript is not detectable either. In fact, the GzmB protein found in the media of MDSC culture was due to T cells or natural killer cells contained in bone marrow and cultured alongside MDSCs. We strengthen this finding by genetically deleting GzmB from the myeloid lineage and measuring tumor burden compared to WT counterpart. Our results show no significant difference in tumor burden, suggesting that even if there is minor expression of GzmB, it is not produced at a functional amount to affect tumor growth. Therefore, this paper proposes alternative theories that align with the known understanding of GzmB expression and secretion. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
5. Visit-Bounded Stack Automata.
- Author
-
Jirásek, Jozef and McQuillan, Ian
- Subjects
TURING machines ,KILLER cells - Abstract
An automaton is k-visit-bounded if during any computation its work tape head visits each tape cell at most k times. In this paper we consider stack automata which are k-visit-bounded for some integer k. This restriction resets the visits when popping (unlike similarly defined Turing machine restrictions) which we show allows the model to accept a proper superset of context-free languages and also a proper superset of languages of visit-bounded Turing machines. We study two variants of visit-bounded stack automata: one where only instructions that move the stack head downwards increase the number of visits of the destination cell, and another where any transition increases the number of visits. We prove that the two types of automata recognize the same languages. We then show that all languages recognized by visit-bounded stack automata are effectively semilinear, and hence are letter-equivalent to regular languages, which can be used to show other properties. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
6. CapsNet-MHC predicts peptide-MHC class I binding based on capsule neural networks.
- Author
-
Kalemati, Mahmood, Darvishi, Saeid, and Koohi, Somayyeh
- Subjects
CAPSULE neural networks ,MAJOR histocompatibility complex ,AMINO acid sequence ,FEATURE extraction ,VACCINE development ,KILLER cells - Abstract
The Major Histocompatibility Complex (MHC) binds to the derived peptides from pathogens to present them to killer T cells on the cell surface. Developing computational methods for accurate, fast, and explainable peptide-MHC binding prediction can facilitate immunotherapies and vaccine development. Various deep learning-based methods rely on separate feature extraction from the peptide and MHC sequences and ignore their pairwise binding information. This paper develops a capsule neural network-based method to efficiently capture the peptide-MHC complex features to predict the peptide-MHC class I binding. Various evaluations confirmed our method outperformance over the alternative methods, while it can provide accurate prediction over less available data. Moreover, for providing precise insights into the results, we explored the essential features that contributed to the prediction. Since the simulation results demonstrated consistency with the experimental studies, we concluded that our method can be utilized for the accurate, rapid, and interpretable peptide-MHC binding prediction to assist biological therapies. A capsule neural network-based method captures pairwise information to accurately predict MHC-I and peptide binding. The comprehensive test of the model indicated both its superiority in performance and interpretability. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. PECDF-CMRP: A Power-Efficient Compressive Data Fusion and Cluster-Based Multi-hop Relay-Assisted Routing Protocol for IoT Sensor Networks.
- Author
-
Agbulu, G. Pius, Kumar, G. Joselin Retnar, Juliet, Vimala A., and Hassan, S. Adurrashid
- Subjects
SENSOR networks ,NETWORK routing protocols ,MULTISENSOR data fusion ,WIRELESS sensor networks ,KILLER cells ,INTERNET of things ,K-means clustering - Abstract
Wireless sensor network (WSN) is the predominantly used technology in building real-time event monitoring and dissemination frameworks for the internet of things (IoT) applications. However, WSN being power-hungry, fragile, and highly susceptible to loss of connectivity, it becomes vital to strengthen the network's communication reliability and energy efficiency. In this paper, a power-efficient compressive data fusion and cluster-based multi-hop relay-assisted protocol (PECDF-CMRP) for IoT sensor networks is proposed. Firstly, K-means algorithm is adapted to assign the nodes into unequal cells. Then cluster heads are nominated by multi-weight functions. Next, relays are chosen from the K cells to establish cooperative networks for data broadcast from the event sectors to the central gateway. The relay allocation is formulated as a maximization problem regarding the node's energy and path loss. The data aggregation is realized with single-level wavelet sparsity-based fusion. Experimental results confirm the supremacy of the proposed PECDF-CMRP in terms of reduced delay and energy consumption with enhanced lifetime and reception-ratio well above related models. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
8. High-Tc Superconducting Memory Cell.
- Author
-
Miloshevsky, Alexander, Nair, Niketh, Imam, Neena, and Braiman, Yehuda
- Subjects
KILLER cells ,JOSEPHSON junctions ,LOGIC design ,HIGH temperature superconductors ,LOW temperatures - Abstract
In this paper, operational principles of a cryogenic memory cell that utilizes high-temperature superconductors (high-T
c ) are presented. Such a cell consists of three inductively coupled Josephson junctions coupled via inductors. Design and operational logic of this type of cell were recently introduced and demonstrated for low temperature 4 K environment. The basic memory cell operations (read, write, reset) can be implemented on the same simple circuit and both destructive and non-destructive memory cell operations can be realized. Here, we present the design principles and computational validation of basic memory cell operations (write, read, and reset) for the high-Tc memory cell. Our results for the high-Tc memory cell operations show very good resemblance with the previously presented low-temperature 4 K memory cell operations. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
9. The correlation of lymphocyte subsets, natural killer cell, and Parkinson's disease: a meta-analysis.
- Author
-
Jiang, Sen, Gao, Hua, Luo, Qin, Wang, Pengfei, and Yang, Xinling
- Subjects
LYMPHOCYTES ,KILLER cells ,PARKINSON'S disease patients ,META-analysis ,CLINICAL trials ,DATABASES ,PARKINSON'S disease ,SYSTEMATIC reviews ,LYMPHOCYTE subsets - Abstract
The correlation between immunity and Parkinson's disease was presented in many papers, which also discussed lymphocyte and natural killer cell. But these studies have yielded inconsistent results. To systematically review the relationship between the lymphocyte subsets/natural killer cell and the risk of Parkinson's disease, we electronically searched the SpringerLink, Web of Science, Ebsco-medline with full text, Pubmed, Elsevier-ScienceDirect, Ovid-lww-oup, Wanfang Data for case-control trials on comparing the number of peripheral blood lymphocyte subsets and natural killer cell in Parkinson's patients and healthy controls. According to the Cochrane methods, the reviewers selected literature, extracted data, and assessed the quality. Then, a meta-analysis was performed using RevMan 5.2. Finally, 21 case-control trials including 943 cases of Parkinson's disease were fit into our data analysis. Meta-analysis showed that the decreased numbers of CD3+, CD4+ lymphocyte subsets and the increased number of natural killer cell were found in Parkinson's disease patients. In the intermediate and late stage of PD, CD8+ lymphocyte subsets had a significant decrement. However, the number of B lymphocyte subsets had no significant association with Parkinson's disease. The lymphocyte subsets and NK cell may be associated with the risk of Parkinson's disease. [ABSTRACT FROM AUTHOR]
- Published
- 2017
- Full Text
- View/download PDF
10. On the Possibility of Determining the Curie Constant and Magnetic Susceptibility of Colloidal Solutions by Method of Nuclear Magnetic Resonance.
- Author
-
Davydov, V. V. and Myazin, N. S.
- Subjects
NUCLEAR magnetic resonance ,MAGNETIC susceptibility ,KILLER cells ,NUCLEAR magnetic resonance spectroscopy - Abstract
A new universal technique was suggested to determine the Curie constant С and magnetic susceptibility of colloidal solutions placed in hermetically sealed vessels (for instance, ferrofluid cells) with an error of no more than 1.0%. Experimental research demonstrated that in the temperature range Т from 283 to 323 K, in which ferrofluid cells are used, the Curie law is fulfilled. It was established that increase in temperature Т of the colloidal solution from 324 to 363 K in a ferrofluid cell leads to an insignificant increase in С, which needs to be taken into account when conducting experiments using these cells. Results of research on colloidal solutions are presented in the paper. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. The Role of NK Cells and Their Exosomes in Graft Versus Host Disease and Graft Versus Leukemia.
- Author
-
Zafarani, Alireza, Taghavi-Farahabadi, Mahsa, Razizadeh, Mohammad Hossein, Amirzargar, Mohammad Reza, Mansouri, Mansoure, and Mahmoudi, Mohammad
- Subjects
- *
GRAFT versus host disease , *KILLER cells , *HEMATOPOIETIC stem cell transplantation , *CYTOMEGALOVIRUS diseases , *EXOSOMES , *VIRUS diseases - Abstract
Natural killer (NK) cells are one of the innate immune cells that play an important role in preventing and controlling tumors and viral diseases, but their role in hematopoietic stem cell transplantation (HCT) is not yet fully understood. However, according to some research, these cells can prevent infections and tumor relapse without causing graft versus host disease (GVHD). In addition to NK cells, several studies are about the anti-leukemia effects of NK cell-derived exosomes that can highlight their roles in graft-versus-leukemia (GVL). In this paper, we intend to investigate the results of various articles on the role of NK cells in allogeneic hematopoietic cell transplantation and also their exosomes in GVL. Also, we have discussed the antiviral effects of these cells in post-HCT cytomegalovirus infection. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
12. Recipient tissue microenvironment determines developmental path of intestinal innate lymphoid progenitors.
- Author
-
Clark, Paula A., Gogoi, Mayuri, Rodriguez-Rodriguez, Noe, Ferreira, Ana C. F., Murphy, Jane E., Walker, Jennifer A., Crisp, Alastair, Jolin, Helen E., Shields, Jacqueline D., and McKenzie, Andrew N. J.
- Subjects
INNATE lymphoid cells ,DIMENSIONAL analysis ,KILLER cells ,CELL populations ,PROGENITOR cells ,LUNGS - Abstract
Innate lymphoid cells (ILCs) are critical in maintaining tissue homeostasis, and during infection and inflammation. Here we identify, by using combinatorial reporter mice, a rare ILC progenitor (ILCP) population, resident to the small intestinal lamina propria (siLP) in adult mice. Transfer of siLP-ILCP into recipients generates group 1 ILCs (including ILC1 and NK cells), ILC2s and ILC3s within the intestinal microenvironment, but almost exclusively group 1 ILCs in the liver, lung and spleen. Single cell gene expression analysis and high dimensional spectral cytometry analysis of the siLP-ILCPs and ILC progeny indicate that the phenotype of the group 1 ILC progeny is also influenced by the tissue microenvironment. Thus, a local pool of siLP-ILCP can contribute to pan-ILC generation in the intestinal microenvironment but has more restricted potential in other tissues, with a greater propensity than bone marrow-derived ILCPs to favour ILC1 and ILC3 production. Therefore, ILCP potential is influenced by both tissue of origin and the microenvironment during development. This may provide additional flexibility during the tuning of immune reactions. The small intestinal lamina propria is rich in innate lymphoid cells, which are important contributors of mucosal immunity. Here authors identify a small progenitor cell population that can develop into all types of innate lymphoid cells in their intestinal microenvironment but their developmental potential becomes more restricted when placed into other tissues, such as liver, lung or spleen. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Natural killer (NK) cells-related gene signature reveals the immune environment heterogeneity in hepatocellular carcinoma based on single cell analysis.
- Author
-
Ye, Zhirong, Li, Wenjun, Ouyang, Hao, Ruan, Zikang, Liu, Xun, Lin, Xiaoxia, and Chen, Xuanting
- Subjects
CYTOTOXIC T cells ,KILLER cells ,TUMOR treatment ,GENE therapy ,LIVER cancer - Abstract
The early diagnosis of liver cancer is crucial for the treatment and depends on the coordinated use of several test procedures. Early diagnosis is crucial for precision therapy in the treatment of the hepatocellular carcinoma (HCC). Therefore, in this study, the NK cell-related gene prediction model was used to provide the basis for precision therapy at the gene level and a novel basis for the treatment of patients with liver cancer. Natural killer (NK) cells have innate abilities to recognize and destroy tumor cells and thus play a crucial function as the "innate counterpart" of cytotoxic T cells. The natural killer (NK) cells is well recognized as a prospective approach for tumor immunotherapy in treating patients with HCC. In this research, we used publicly available databases to collect bioinformatics data of scRNA-seq and RNA-seq from HCC patients. To determine the NK cell-related genes (NKRGs)-based risk profile for HCC, we isolated T and natural killer (NK) cells and subjected them to analysis. Uniform Manifold Approximation and Projection plots were created to show the degree of expression of each marker gene and the distribution of distinct clusters. The connection between the immunotherapy response and the NKRGs-based signature was further analyzed, and the NKRGs-based signature was established. Eventually, a nomogram was developed using the model and clinical features to precisely predict the likelihood of survival. The prognosis of HCC can be accurately predicted using the NKRGs-based prognostic signature, and thorough characterization of the NKRGs signature of HCC may help to interpret the response of HCC to immunotherapy and propose a novel tumor treatment perspective. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. CD24 affects the immunosuppressive effect of tumor-infiltrating cells and tumor resistance in a variety of cancers.
- Author
-
Zhao, Chunmei, Huang, Ying, Zhang, Haotian, and Liu, Huimin
- Subjects
MYELOID-derived suppressor cells ,MYELOID cells ,IMMUNE checkpoint proteins ,KILLER cells ,CELL cycle - Abstract
Background: Cluster of differentiation 24 (CD24) is a highly glycosylated glycosylphosphatidylinositol (GPI)-anchored surface protein, expressed in various tumor cells, as a "don't eat me" signaling molecule in tumor immune. This study aimed to investigate the potential features of CD24 in pan-cancer. Methods: The correlations between 22 immune cells and CD24 expression were using TIMER analysis. R package "ESTIMATE" was used to predict the proportion of immune and stromal cells in pan-cancer. Spearman's correlation analysis was performed to evaluate the relationships between CD24 expression and immune checkpoints, chemokines, mismatch repair, tumor mutation burden and microsatellite instability, and qPCR and western blot were conducted to assess CD24 expression levels in liver hepatocellular carcinoma (LIHC). In addition, loss of function was performed for the biological evaluation of CD24 in LIHC. Results: CD24 expression was positively correlated with myeloid cells, including neutrophils and myeloid-derived suppressor cells, in various tumors, such as BLCA, HNSC-HPV, HNSC, KICH, KIRC, KIRP, TGCT, THCA, THYM, and UCEC. In contrast, anti-tumor NK cells and NKT cells showed a negative association with CD24 expression in BRCA-Her2, ESCA, HNSC-HPV, KIRC, THCA, and THYM. The top three tumors with the highest correlation between CD24 and ImmuneScore were TGCT, THCA, and SKCM. Functional enrichment analysis revealed CD24 expression was negatively associated with various immune-related pathways. Immune checkpoints and chemokines also exhibited inverse correlations with CD24 in CESC, CHOL, COAD, ESCA, READ, TGCT, and THCA. Additionally, CD24 was overexpressed in most tumors, with high CD24 expression in BRCA, LIHC, and CESC correlating with poor prognosis. The TIDE database indicated tumors with high CD24 expression, particularly melanoma, were less responsive to PD1/PD-L1 immunotherapy. Finally, CD24 knockdown resulted in impaired proliferation and cell cycle progression in LIHC. Conclusion: CD24 participates in regulation of immune infiltration, influences patient prognosis and serves as a potential tumor marker. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
15. Simulated microgravity impairs human NK cell cytotoxic activity against space radiation-relevant leukemic cells.
- Author
-
Kuhlman, Bradford M., Diaz, Jonathan H., Simon, Trang, Reeves, Kimberly D., Walker, Stephen J., Atala, Anthony, Almeida-Porada, Graça, and Porada, Christopher D.
- Subjects
REDUCED gravity environments ,KILLER cells ,CYTOTOXINS ,ASTROPHYSICAL radiation ,CANCER cells ,DISEASE risk factors - Abstract
Natural killer (NK) cells are an important first-line of defense against malignant cells. Because of the potential for increased cancer risk from astronaut exposure to space radiation, we determined whether microgravity present during spaceflight affects the body's defenses against leukemogenesis. Human NK cells were cultured for 48 h under normal gravity and simulated microgravity (sμG), and cytotoxicity against K-562 (CML) and MOLT-4 (T-ALL) cells was measured using standard methodology or under continuous sμG. This brief exposure to sμG markedly reduced NK cytotoxicity against both leukemias, and these deleterious effects were more pronounced in continuous sμG. RNA-seq performed on NK cells from two additional healthy donors provided insight into the mechanism(s) by which sμG reduced cytotoxicity. Given our prior report of space radiation-induced human T-ALL in vivo, the reduced cytotoxicity against MOLT-4 is striking and raises the possibility that μG may increase astronaut risk of leukemogenesis during prolonged missions beyond LEO. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Lectin-like transcript 1 (LLT1) expression is associated with nodal metastasis in patients with head and neck cutaneous squamous cell carcinoma.
- Author
-
Santos-Juanes, J., Fernández-Vega, I., Lorenzo-Herrero, S., Sordo-Bahamonde, C., Martínez-Camblor, P., García-Pedrero, J. M., Vivanco, B., Galache-Osuna, C., Vazquez-Lopez, F., Gonzalez, S., and Rodrigo, J. P.
- Subjects
SQUAMOUS cell carcinoma ,KILLER cells ,PROPORTIONAL hazards models ,METASTASIS - Abstract
The interaction of lectin-like transcript 1 (LLT1) with CD161 inhibits Natural Killer cell activation. Overexpression of LLT1 contributes to the immunosuppressive properties of tumor cells. However, there are little data about LLT1 expression in human solid tumors. The objective of this paper is to investigate the relationship between LLT1 expression with the clinicopathologic features and its impact on the prognosis of head and neck cutaneous squamous cell carcinoma (cSCC). LLT1 expression was analyzed on paraffin-embedded tissue samples obtained from 100 patients with cSCC by immunohistochemistry. The estimator of Fine and Gray was used to estimate the cumulative incidence curves for relapse. Proportional Hazard models and Hazard ratios (HRs) were used for studying the risk of tumor relapse and mortality. LLT1 strong expression was a significant risk factor for nodal metastasis with crude and adjusted ratios (HRs) of 3.40 (95% CI 1.39–9.28) and 3.25 (95% CI 1.15–9.16); and for cSCC specific death of 6.17 (95% CI 1.79–21.2) and 6.10 (95% CI 1.45–25.7). Strong LLT1 expression is an independent predictor of nodal metastasis and poor disease-specific survival and it might be helpful for risk stratification of patients with cSCC. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
17. Expression and function of immune ligand-receptor pairs in NK cells and cancer stem cells: therapeutic implications.
- Author
-
Voutsadakis, Ioannis A.
- Subjects
KILLER cells ,CANCER stem cells ,IMMUNE system ,CANCER treatment ,IMMUNOTHERAPY - Abstract
Background: The interplay between the immune system and cancer cells has come to the forefront of cancer therapeutics, with novel immune blockade inhibitors being approved for the treatment of an increasing list of cancers. However, the majority of cancer patients still display or develop resistance to these promising drugs. It is possible that cancer stem cells (CSCs) are contributing to this therapeutic resistance. Although CSCs usually represent a small percentage of the total number of cancer cells, they are endowed with the ability of self-renewal and to produce differentiated progeny. Additionally, they have shown the capacity to establish tumors after transplantation to animals, even in small numbers. CSCs have also been found to be resistant to various anti-cancer therapies, including chemotherapy, radiation therapy and, more recently, immunotherapy. This is true despite the sensitivity of CSCs to lysis
in vitro by natural killer (NK) cells, the main effector cells of the innate immune system. In this paper the expression of ligands specific for NK cells on CSCs, the intracellular network responsible for the expression of the NK cytotoxicity receptors, and the status of activation of NK cells in the tumor micro-environment are reviewed. The aim of this review is to highlight potential strategies for overcoming CSC immune resistance, thereby enhancing the efficacy of current and future anti-cancer therapies.Therapeutic implications: NK cell activation in the tumor micro-environment through drugs neutralizing inhibitory immune receptors, and combined with other drugs harnessing the potential of the adaptive immune system, could be the most effective approach for attacking both stem cell and non-stem cell cancer populations. [ABSTRACT FROM AUTHOR]- Published
- 2018
- Full Text
- View/download PDF
18. Single-cell profiling identifies a CD8bright CD244bright Natural Killer cell subset that reflects disease activity in HLA-A29-positive birdshot chorioretinopathy.
- Author
-
Nath, Pulak R., Maclean, Mary, Nagarajan, Vijay, Lee, Jung Wha, Yakin, Mehmet, Kumar, Aman, Nadali, Hadi, Schmidt, Brian, Kaya, Koray D., Kodati, Shilpa, Young, Alice, Caspi, Rachel R., Kuiper, Jonas J. W., and Sen, H. Nida
- Subjects
KILLER cells ,T cells ,CELL receptors ,CELLULAR recognition ,CELL populations - Abstract
Birdshot chorioretinopathy is an inflammatory eye condition strongly associated with MHC-I allele HLA-A29. The striking association with MHC-I suggests involvement of T cells, whereas natural killer (NK) cell involvement remains largely unstudied. Here we show that HLA-A29-positive birdshot chorioretinopathy patients have a skewed NK cell pool containing expanded CD16 positive NK cells which produce more proinflammatory cytokines. These NK cells contain populations that express CD8A which is involved in MHC-I recognition on target cells, display gene signatures indicative of high cytotoxic activity (GZMB, PRF1 and ISG15), and signaling through NK cell receptor CD244 (SH2D1B). Long-term monitoring of a cohort of birdshot chorioretinopathy patients with active disease identifies a population of CD8
bright CD244bright NK cells, which rapidly declines to normal levels upon clinical remission following successful treatment. Collectively, these studies implicate CD8bright CD244bright NK cells in birdshot chorioretinopathy. Birdshot chorioretinopathy is an inflammatory eye condition strongly associated with HLA-A29. Here the authors use a single cell RNA sequencing approach to characterise NK cell involvement in this disease and show that CD8bright CD244bright NK cells are associated with active disease. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
19. Genomic and immune determinants of resistance to daratumumab-based therapy in relapsed refractory multiple myeloma.
- Author
-
Ziccheddu, Bachisio, Giannotta, Claudia, D'Agostino, Mattia, Bertuglia, Giuseppe, Saraci, Elona, Oliva, Stefania, Genuardi, Elisa, Papadimitriou, Marios, Diamond, Benjamin, Corradini, Paolo, Coffey, David, Landgren, Ola, Bolli, Niccolò, Bruno, Benedetto, Boccadoro, Mario, Massaia, Massimo, Maura, Francesco, and Larocca, Alessandra
- Subjects
REGULATORY T cells ,WHOLE genome sequencing ,T-cell exhaustion ,KILLER cells ,MULTIPLE myeloma - Abstract
Targeted immunotherapy combinations, including the anti-CD38 monoclonal antibody (MoAb) daratumumab, have shown promising results in patients with relapsed/refractory multiple myeloma (RRMM), leading to a considerable increase in progression-free survival. However, a large fraction of patients inevitably relapse. To understand this, we investigated 32 relapsed MM patients treated with daratumumab, lenalidomide, and dexamethasone (Dara-Rd; NCT03848676). We conducted an integrated analysis using whole-genome sequencing (WGS) and flow cytometry in patients with RRMM. WGS before and after treatment pinpointed genomic drivers associated with early progression, including RPL5 loss, APOBEC mutagenesis, and gain of function structural variants involving MYC and chromothripsis. Flow cytometry on 202 blood samples, collected every 3 months until progression for 31 patients, revealed distinct immune changes significantly impacting clinical outcomes. Progressing patients exhibited significant depletion of CD38-positive NK cells, persistence of T-cell exhaustion, and reduced depletion of regulatory T cells over time. These findings underscore the influence of immune composition and daratumumab-induced immune changes in promoting MM resistance. Integrating genomics and flow cytometry unveiled associations between adverse genomic features and immune patterns. Overall, this study sheds light on the intricate interplay between genomic complexity and the immune microenvironment driving resistance to Dara-Rd in patients with RRMM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
20. Harnessing virus flexibility to selectively capture and profile rare circulating target cells for precise cancer subtyping.
- Author
-
Li, Hui-Da, Chen, Yuan-Qiang, Li, Yan, Wei, Xing, Wang, Si-Yi, Cao, Ying, Wang, Rui, Wang, Cong, Li, Jing-Yue, Li, Jian-Yi, Ding, Hong-Ming, Yang, Ting, Wang, Jian-Hua, and Mao, Chuanbin
- Subjects
LEUCOCYTES ,YOUNG'S modulus ,CELL receptors ,CANCER cells ,BACTERIOPHAGES ,KILLER cells ,REPRODUCTIVE isolation - Abstract
The effective isolation of rare target cells, such as circulating tumor cells, from whole blood is still challenging due to the lack of a capturing surface with strong target-binding affinity and non-target-cell resistance. Here we present a solution leveraging the flexibility of bacterial virus (phage) nanofibers with their sidewalls displaying target circulating tumor cell-specific aptamers and their ends tethered to magnetic beads. Such flexible phages, with low stiffness and Young's modulus, can twist and adapt to recognize the cell receptors, energetically enhancing target cell capturing and entropically discouraging non-target cells (white blood cells) adsorption. The magnetic beads with flexible phages can isolate and count target cells with significant increase in cell affinity and reduction in non-target cell absorption compared to magnetic beads having rigid phages. This differentiates breast cancer patients and healthy donors, with impressive area under the curve (0.991) at the optimal detection threshold (>4 target cells mL
−1 ). Immunostaining of captured circulating tumor cells precisely determines breast cancer subtypes with a diagnostic accuracy of 91.07%. Our study reveals the power of viral mechanical attributes in designing surfaces with superior target binding and non-target anti-fouling. The effective isolation of rare target cells, such as circulating tumor cells from whole blood is still challenging. Here, the authors utilize adaptable flexible M13 phage in constructing magnetic beads, forming a deformable surface that can tightly capture CTCs. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
21. Comprehensive bioinformatics analysis of integrator complex subunits: expression patterns, immune infiltration, and prognostic signature, validated through experimental approaches in hepatocellular carcinoma.
- Author
-
Xu, Yifei, Liao, Wenlian, Wang, Ting, Zhang, Liwei, and Zhang, Hui
- Subjects
GENE expression ,REVERSE transcriptase polymerase chain reaction ,RNA polymerase II ,KILLER cells ,LIVER cells ,HEPATOCELLULAR carcinoma - Abstract
Background: Hepatocellular carcinoma (HCC) is a common gastrointestinal malignancy with a high incidence and poor prognosis. The subunits of the integrator complex (INTS1-14) play a crucial role in regulating genes dependent on RNA Polymerase II, which may be associated with cancer. However, the role of INTSs in HCC remains unclear. This study aims to comprehensively analyze the clinical value and potential role of INTS family genes in HCC through systematic bioinformatics analysis. Methods: We employed various public databases, including UALCAN, HPA, Kaplan–Meier Plotter, GEPIA2, TNMplot, STRING, TIMER, and TISIDB, to investigate the expression levels, clinicopathological correlations, diagnostic and prognostic value, genetic alterations, co-expression network, molecular targets, and immune infiltration of INTSs in HCC. Additionally, Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) were utilized to investigate the biological functions of genes associated with INTSs. Furthermore, Western blot, real-time fluorescence quantitative reverse transcription polymerase chain reaction (RT-qPCR), and immunohistochemistry techniques were employed to assess the expression of relevant proteins and genes. The proliferation of HCC cells was evaluated using the CCK8 assay. Results: We found that in HCC, there was a significant upregulation of INTSs at the transcriptional level, particularly INTS1, INTS4, INTS7, and INTS8. Additionally, the protein levels of INTS1 and INTS8 were notably elevated. The overexpression of these INTSs was strongly correlated with tumor stages in HCC patients. INTS1, INTS4, INTS7, and INTS8 exhibited significant diagnostic and prognostic value in HCC. Moreover, their expression was associated with immune infiltrations and activated status, including B cells, CD8 + T cells, CD4 + T cells, NK cells, macrophages, and dendritic cells. Functional predictions indicated that INTS1, INTS4, INTS7, and INTS8 were involved in various cancer-related signaling pathways, such as TRAIL, IFN-gamma, mTOR, CDC42, Apoptosis, and the p53 pathway. Furthermore, we observed a significant upregulation of INTS1, INTS4, INTS7, and INTS8 expression in HCC cell lines compared to normal liver cell lines. The level of INTS1 protein was higher in cancerous tissues compared to adjacent non-cancerous tissues (n = 16), and the suppression of INTS1 resulted in a significant decrease in the proliferation of Huh7 cells. Conclusion: These findings indicate the potential of INTS family genes as diagnostic biomarkers and therapeutic targets in HCC. Further research is needed to understand the underlying mechanisms and explore clinical applications. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
22. NCF4 attenuates colorectal cancer progression by modulating inflammasome activation and immune surveillance.
- Author
-
Li, Longjun, Mao, Rudi, Yuan, Shenli, Xie, Qingqing, Meng, Jinyu, Gu, Yu, Tan, Siyu, Xu, Xiaoqing, Gao, Chengjiang, Liu, Hongbin, Ma, Chunhong, Man, Si Ming, Meng, Xiangbo, Xu, Tao, and Qi, Xiaopeng
- Subjects
COLORECTAL cancer ,INFLAMMASOMES ,CANCER invasiveness ,NADPH oxidase ,KILLER cells ,IMMUNOPRECIPITATION - Abstract
The spatiotemporal regulation of inflammasome activation remains unclear. To examine the mechanism underlying the assembly and regulation of the inflammasome response, here we perform an immunoprecipitation-mass spectrometry analysis of apoptosis-associated speck-like protein containing a CARD (ASC) and identify NCF4/1/2 as ASC-binding proteins. Reduced NCF4 expression is associated with colorectal cancer development and decreased five-year survival rate in patients with colorectal cancer. NCF4 cooperates with NCF1 and NCF2 to promote NLRP3 and AIM2 inflammasome activation. Mechanistically, NCF4 phosphorylation and puncta distribution switches from the NADPH complex to the perinuclear region, mediating ASC oligomerization, speck formation and inflammasome activation. NCF4 functions as a sensor of ROS levels, to establish a balance between ROS production and inflammasome activation. NCF4 deficiency causes severe colorectal cancer in mice, increases transit-amplifying and precancerous cells, reduces the frequency and activation of CD8
+ T and NK cells, and impairs the inflammasome-IL-18-IFN-γ axis during the early phase of colorectal tumorigenesis. Our study implicates NCF4 in determining the spatial positioning of inflammasome assembly and contributing to inflammasome-mediated anti-tumor responses. The NADPH oxidase 2 (NOX2) complex is a main reactive oxygen species (ROS) source during inflammation. Here the authors report that NCF4, a subunit of the NOX2 complex, acts a sensor of ROS levels and regulates NLRP3 and AIM2 inflammasome activation, associated with attenuated colorectal cancer progression. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
23. Single-cell analysis identifies conserved features of immune dysfunction in simulated microgravity and spaceflight.
- Author
-
Wu, Fei, Du, Huixun, Overbey, Eliah, Kim, JangKeun, Makhijani, Priya, Martin, Nicolas, Lerner, Chad A., Nguyen, Khiem, Baechle, Jordan, Valentino, Taylor R., Fuentealba, Matias, Bartleson, Juliet M., Halaweh, Heather, Winer, Shawn, Meydan, Cem, Garrett-Bakelman, Francine, Sayed, Nazish, Melov, Simon, Muratani, Masafumi, and Gerencser, Akos A.
- Subjects
MONONUCLEAR leukocytes ,REDUCED gravity environments ,SPACE flight ,TOLL-like receptors ,INTERFERON receptors ,KILLER cells - Abstract
Microgravity is associated with immunological dysfunction, though the mechanisms are poorly understood. Here, using single-cell analysis of human peripheral blood mononuclear cells (PBMCs) exposed to short term (25 hours) simulated microgravity, we characterize altered genes and pathways at basal and stimulated states with a Toll-like Receptor-7/8 agonist. We validate single-cell analysis by RNA sequencing and super-resolution microscopy, and against data from the Inspiration-4 (I4) mission, JAXA (Cell-Free Epigenome) mission, Twins study, and spleens from mice on the International Space Station. Overall, microgravity alters specific pathways for optimal immunity, including the cytoskeleton, interferon signaling, pyroptosis, temperature-shock, innate inflammation (e.g., Coronavirus pathogenesis pathway and IL-6 signaling), nuclear receptors, and sirtuin signaling. Microgravity directs monocyte inflammatory parameters, and impairs T cell and NK cell functionality. Using machine learning, we identify numerous compounds linking microgravity to immune cell transcription, and demonstrate that the flavonol, quercetin, can reverse most abnormal pathways. These results define immune cell alterations in microgravity, and provide opportunities for countermeasures to maintain normal immunity in space. The phenotype and function of immune cells could change during spaceflight. Here the authors use simulated microgravity, coupled to validation with spaceflight data, to assess whether there are distinct gene expression changes in resting and TLR 7/8 stimulated PBMCs and found conserved changes in IFN signalling, the cytoskeleton, IL-6 and sirtuin signalling. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
24. Cis-regulatory evolution of the recently expanded Ly49 gene family.
- Author
-
Fan, Changxu, Xing, Xiaoyun, Murphy, Samuel J. H., Poursine-Laurent, Jennifer, Schmidt, Heather, Parikh, Bijal A., Yoon, Jeesang, Choudhary, Mayank N. K., Saligrama, Naresha, Piersma, Sytse J., Yokoyama, Wayne M., and Wang, Ting
- Subjects
GENE families ,KILLER cell receptors ,CIS-regulatory elements (Genetics) ,KILLER cells ,COMPARATIVE genomics - Abstract
Comparative genomics has revealed the rapid expansion of multiple gene families involved in immunity. Members within each gene family often evolved distinct roles in immunity. However, less is known about the evolution of their epigenome and cis-regulation. Here we systematically profile the epigenome of the recently expanded murine Ly49 gene family that mainly encode either inhibitory or activating surface receptors on natural killer cells. We identify a set of cis-regulatory elements (CREs) for activating Ly49 genes. In addition, we show that in mice, inhibitory and activating Ly49 genes are regulated by two separate sets of proximal CREs, likely resulting from lineage-specific losses of CRE activity. Furthermore, we find that some Ly49 genes are cross-regulated by the CREs of other Ly49 genes, suggesting that the Ly49 family has begun to evolve a concerted cis-regulatory mechanism. Collectively, we demonstrate the different modes of cis-regulatory evolution for a rapidly expanding gene family. The Ly49 gene family mainly encodes inhibitory or activating surface receptors on natural killer cells. Here the authors show that in mice, inhibitory and activating Ly49 genes are regulated by two distinct sets of cis-regulatory elements, and that different Ly49 genes can be cross-regulated. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
25. Single-cell and spatial transcriptomics analysis of non-small cell lung cancer.
- Author
-
De Zuani, Marco, Xue, Haoliang, Park, Jun Sung, Dentro, Stefan C., Seferbekova, Zaira, Tessier, Julien, Curras-Alonso, Sandra, Hadjipanayis, Angela, Athanasiadis, Emmanouil I., Gerstung, Moritz, Bayraktar, Omer, and Cvejic, Ana
- Subjects
NON-small-cell lung carcinoma ,TRANSCRIPTOMES ,CELL analysis ,MYELOID cells ,KILLER cells ,MOLECULAR pathology - Abstract
Lung cancer is the second most frequently diagnosed cancer and the leading cause of cancer-related mortality worldwide. Tumour ecosystems feature diverse immune cell types. Myeloid cells, in particular, are prevalent and have a well-established role in promoting the disease. In our study, we profile approximately 900,000 cells from 25 treatment-naive patients with adenocarcinoma and squamous-cell carcinoma by single-cell and spatial transcriptomics. We note an inverse relationship between anti-inflammatory macrophages and NK cells/T cells, and with reduced NK cell cytotoxicity within the tumour. While we observe a similar cell type composition in both adenocarcinoma and squamous-cell carcinoma, we detect significant differences in the co-expression of various immune checkpoint inhibitors. Moreover, we reveal evidence of a transcriptional "reprogramming" of macrophages in tumours, shifting them towards cholesterol export and adopting a foetal-like transcriptional signature which promotes iron efflux. Our multi-omic resource offers a high-resolution molecular map of tumour-associated macrophages, enhancing our understanding of their role within the tumour microenvironment. Myeloid cell populations play a critical role in lung cancer progression. Here, the authors use scRNA-seq and spatial transcriptomics to identify changes in the phenotype of macrophages within the tumour microenvironment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
26. Redirecting NK cells to the lymph nodes to augment their lymphoma-targeting capacity.
- Author
-
Sanz-Ortega, Laura, Leijonhufvud, Caroline, Schoutens, Lisanne, Lambert, Mélanie, Levy, Emily, Andersson, Agneta, Wahlin, Björn E., and Carlsten, Mattias
- Subjects
KILLER cells ,LYMPH nodes ,GENETIC engineering ,CHEMOKINE receptors ,HOME (The concept) - Abstract
CAR-NK cells can induce remission in lymphoma patients. We speculate that the full potential of adoptive NK cell immunotherapy against lymphoma is restricted by their poor lymph node (LN) homing capacity. Here, we have utilized a clinically approved transfection method with the aim of redirecting NK cells to LNs. Electroporation of ex vivo expanded NK cells with mRNAs coding for CCR7, CXCR5, and CD62L resulted in increased in vitro migration towards chemokines and mouse LN-derived supernatant. Following infusion into SCID/Beige mice, modified NK cells showed enhanced LN homing. Importantly, lymphoma patient-derived NK cells were equally well expanded and engineered as healthy donor NK cells, highlighting their translational potential. Additionally, the introduction of high-affinity CD16, together with the homing molecules, also augmented their ADCC capacity against autologous lymphoma cells. Hence, genetic engineering can be utilized to enhance NK cell LN homing. The homing concept may synergize with CAR- or monoclonal/bi-/tri-specific antibody-based approaches. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
27. Enhanced CD95 and interleukin 18 signalling accompany T cell receptor Vβ21.3+ activation in multi-inflammatory syndrome in children.
- Author
-
Zhang, Zhenguang, Kean, Iain R. L., Dratva, Lisa M., Clark, John A., Syrimi, Eleni, Khan, Naeem, Daubney, Esther, White, Deborah, O'Neill, Lauran, Chisholm, Catherine, Payne, Caroline, Benkenstein, Sarah, Kupiec, Klaudia, Galassini, Rachel, Wright, Victoria, Winmill, Helen, Robbins, Ceri, Brown, Katherine, Ramnarayan, Padmanabhan, and Scholefield, Barnaby
- Subjects
T cells ,T cell receptors ,MULTISYSTEM inflammatory syndrome in children ,SYNDROMES in children ,INTERLEUKIN receptors ,KILLER cells ,REGULATORY T cells ,KILLER cell receptors - Abstract
Multisystem inflammatory syndrome in children is a post-infectious presentation SARS-CoV-2 associated with expansion of the T cell receptor Vβ21.3+ T-cell subgroup. Here we apply muti-single cell omics to compare the inflammatory process in children with acute respiratory COVID-19 and those presenting with non SARS-CoV-2 infections in children. Here we show that in Multi-Inflammatory Syndrome in Children (MIS-C), the natural killer cell and monocyte population demonstrate heightened CD95 (Fas) and Interleuking 18 receptor expression. Additionally, TCR Vβ21.3+ CD4+ T-cells exhibit skewed differentiation towards T helper 1, 17 and regulatory T cells, with increased expression of the co-stimulation receptors ICOS, CD28 and interleukin 18 receptor. We observe no functional evidence for NLRP3 inflammasome pathway overactivation, though MIS-C monocytes show elevated active caspase 8. This, coupled with raised IL18 mRNA expression in CD16- NK cells on single cell RNA sequencing analysis, suggests interleukin 18 and CD95 signalling may trigger activation of TCR Vβ21.3+ T-cells in MIS-C, driven by increased IL-18 production from activated monocytes and CD16- Natural Killer cells. Multi-Inflammatory Syndrome in Children (MIS-C) is a severe post-infectious presentation related to SARS-CoV-2 infection. Here authors used multi-omics approaches to characterise MIS-C cases and found increased CD95 and IL-18 signalling accompanying the expansion of TCR Vβ 21.3+ T cells. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
28. Premature skewing of T cell receptor clonality and delayed memory expansion in HIV-exposed infants.
- Author
-
Dzanibe, Sonwabile, Wilk, Aaron J., Canny, Susan, Ranganath, Thanmayi, Alinde, Berenice, Rubelt, Florian, Huang, Huang, Davis, Mark M., Holmes, Susan P., Jaspan, Heather B., Blish, Catherine A., and Gray, Clive M.
- Subjects
T cells ,IMMUNOLOGIC memory ,T cell differentiation ,KILLER cells ,INFANTS ,HIV infection transmission - Abstract
While preventing vertical HIV transmission has been very successful, HIV-exposed uninfected infants (iHEU) experience an elevated risk to infections compared to HIV-unexposed and uninfected infants (iHUU). Here we present a longitudinal multimodal analysis of infant immune ontogeny that highlights the impact of HIV/ARV exposure. Using mass cytometry, we show alterations in T cell memory differentiation between iHEU and iHUU being significant from week 15 of life. The altered memory T cell differentiation in iHEU was preceded by lower TCR Vβ clonotypic diversity and linked to TCR clonal depletion within the naïve T cell compartment. Compared to iHUU, iHEU had elevated CD56
lo CD16lo Perforin+ CD38+ CD45RA+ FcεRIγ+ NK cells at 1 month postpartum and whose abundance pre-vaccination were predictive of vaccine-induced pertussis and rotavirus antibody responses post 3 months of life. Collectively, HIV/ARV exposure disrupted the trajectory of innate and adaptive immunity from birth which may underlie relative vulnerability to infections in iHEU. Here, Dzanibe et al show that in utero HIV/ARV exposure sequentially disrupts infant immunologic trajectories, beginning with NK cells that predict vaccine antibody responses and followed by delayed T cell memory maturation linked to skewed TCR clonality. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
29. Pretreatment with IL-15 and IL-18 rescues natural killer cells from granzyme B-mediated apoptosis after cryopreservation.
- Author
-
Berjis, Abdulla, Muthumani, Deeksha, Aguilar, Oscar A., Pomp, Oz, Johnson, Omar, Finck, Amanda V., Engel, Nils W., Chen, Linhui, Plachta, Nicolas, Scholler, John, Lanier, Lewis L., June, Carl H., and Sheppard, Neil C.
- Subjects
CRYOPROTECTIVE agents ,GRANZYMES ,KILLER cells ,FROZEN semen ,T cells ,APOPTOSIS ,GENOME editing ,CYTOTOXINS - Abstract
Human natural killer (NK) cell-based therapies are under assessment for treating various cancers, but cryopreservation reduces both the recovery and function of NK cells, thereby limiting their therapeutic feasibility. Using cryopreservation protocols optimized for T cells, here we find that ~75% of NK cells die within 24 h post-thaw, with the remaining cells displaying reduced cytotoxicity. Using CRISPR-Cas9 gene editing and confocal microscopy, we find that cryopreserved NK cells largely die via apoptosis initiated by leakage of granzyme B from cytotoxic vesicles. Pretreatment of NK cells with a combination of Interleukins-15 (IL-15) and IL-18 prior to cryopreservation improves NK cell recovery to ~90-100% and enables equal tumour control in a xenograft model of disseminated Raji cell lymphoma compared to non-cryopreserved NK cells. The mechanism of IL-15 and IL-18-induced protection incorporates two mechanisms: a transient reduction in intracellular granzyme B levels via degranulation, and the induction of antiapoptotic genes. Natural killer (NK) cells are assessed for various therapies, but sub-optimal cryopreservation dampens their clinical feasibility. Here the authors show that pretreating human NK cells with IL-15/IL-18 prior to cryopreservation improves NK cell post-thaw viability and functions, potentially via anti-apoptosis gene induction and granzyme B degranulation. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
30. Trade-offs shaping transmission of sylvatic dengue and Zika viruses in monkey hosts.
- Author
-
Hanley, Kathryn A., Cecilia, Hélène, Azar, Sasha R., Moehn, Brett A., Gass, Jordan T., Oliveira da Silva, Natalia I., Yu, Wanqin, Yun, Ruimei, Althouse, Benjamin M., Vasilakis, Nikos, and Rossi, Shannan L.
- Subjects
SIMIAN viruses ,CERCOPITHECIDAE ,ZIKA virus ,DENGUE viruses ,SQUIRREL monkeys ,DENGUE ,KILLER cells ,MOSQUITO control - Abstract
Mosquito-borne dengue (DENV) and Zika (ZIKV) viruses originated in Old World sylvatic (forest) cycles involving monkeys and canopy-living Aedes mosquitoes. Both viruses spilled over into human transmission and were translocated to the Americas, opening a path for spillback into Neotropical sylvatic cycles. Studies of the trade-offs that shape within-host dynamics and transmission of these viruses are lacking, hampering efforts to predict spillover and spillback. We infected a native, Asian host species (cynomolgus macaque) and a novel, American host species (squirrel monkey) with sylvatic strains of DENV-2 or ZIKV via mosquito bite. We then monitored aspects of viral replication (viremia), innate and adaptive immune response (natural killer (NK) cells and neutralizing antibodies, respectively), and transmission to mosquitoes. In both hosts, ZIKV reached high titers that translated into high transmission to mosquitoes; in contrast DENV-2 replicated to low levels and, unexpectedly, transmission occurred only when serum viremia was below or near the limit of detection. Our data reveal evidence of an immunologically-mediated trade-off between duration and magnitude of virus replication, as higher peak ZIKV titers are associated with shorter durations of viremia, and higher NK cell levels are associated with lower peak ZIKV titers and lower anti-DENV-2 antibody levels. Furthermore, patterns of transmission of each virus from a Neotropical monkey suggest that ZIKV has greater potential than DENV-2 to establish a sylvatic transmission cycle in the Americas. Hanley et al show that transmission of dengue and Zika virus from Old and New World monkeys is shaped by an immunologically-mediated trade-off between magnitude and duration of replication. Patterns of Zika transmission suggests high risk of spillback into neotropical monkeys. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
31. BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3.
- Author
-
Reggiani, Francesca, Talarico, Giovanna, Gobbi, Giulia, Sauta, Elisabetta, Torricelli, Federica, Manicardi, Veronica, Zanetti, Eleonora, Orecchioni, Stefania, Falvo, Paolo, Piana, Simonetta, Lococo, Filippo, Paci, Massimiliano, Bertolini, Francesco, Ciarrocchi, Alessia, and Sancisi, Valentina
- Subjects
NON-small-cell lung carcinoma ,SMAD proteins ,CELL receptors ,KILLER cells ,IMMUNE checkpoint proteins - Abstract
Non-small-cell lung carcinoma (NSCLC) is the most common lung cancer and one of the pioneer tumors in which immunotherapy has radically changed patients' outcomes. However, several issues are emerging and their implementation is required to optimize immunotherapy-based protocols. In this work, we investigate the ability of the Bromodomain and Extra-Terminal protein inhibitors (BETi) to stimulate a proficient anti-tumor immune response toward NSCLC. By using in vitro, ex-vivo, and in vivo models, we demonstrate that these epigenetic drugs specifically enhance Natural Killer (NK) cell cytotoxicity. BETi down-regulate a large set of NK inhibitory receptors, including several immune checkpoints (ICs), that are direct targets of the transcriptional cooperation between the BET protein BRD4 and the transcription factor SMAD3. Overall, BETi orchestrate an epigenetic reprogramming that leads to increased recognition of tumor cells and the killing ability of NK cells. Our results unveil the opportunity to exploit and repurpose these drugs in combination with immunotherapy. Combination of BET inhibitors (BETi) with immunotherapy has been reported to be synergic for the treatment of non-small cell lung carcinoma (NSCLC). Here, the authors show that BETi-induced epigenetic reprogramming downregulates the expression of NK cell inhibitory receptors on NK cells, increasing their activation and cytotoxicity against NSCLC. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
32. Oncogenic enhancers prime quiescent metastatic cells to escape NK immune surveillance by eliciting transcriptional memory.
- Author
-
Michelatti, Daniela, Beyes, Sven, Bernardis, Chiara, Negri, Maria Luce, Morelli, Leonardo, Bediaga, Naiara Garcia, Poli, Vittoria, Fagnocchi, Luca, Lago, Sara, D'Annunzio, Sarah, Cona, Nicole, Gaspardo, Ilaria, Bianchi, Aurora, Jovetic, Jovana, Gianesello, Matteo, Turdo, Alice, D'Accardo, Caterina, Gaggianesi, Miriam, Dori, Martina, and Forcato, Mattia
- Subjects
KILLER cells ,PHENOTYPIC plasticity ,METASTASIS ,MEMORY ,TRETINOIN ,RETINOIC acid receptors - Abstract
Metastasis arises from disseminated tumour cells (DTCs) that are characterized by intrinsic phenotypic plasticity and the capability of seeding to secondary organs. DTCs can remain latent for years before giving rise to symptomatic overt metastasis. In this context, DTCs fluctuate between a quiescent and proliferative state in response to systemic and microenvironmental signals including immune-mediated surveillance. Despite its relevance, how intrinsic mechanisms sustain DTCs plasticity has not been addressed. By interrogating the epigenetic state of metastatic cells, we find that tumour progression is coupled with the activation of oncogenic enhancers that are organized in variable interconnected chromatin domains. This spatial chromatin context leads to the activation of a robust transcriptional response upon repeated exposure to retinoic acid (RA). We show that this adaptive mechanism sustains the quiescence of DTCs through the activation of the master regulator SOX9. Finally, we determine that RA-stimulated transcriptional memory increases the fitness of metastatic cells by supporting the escape of quiescent DTCs from NK-mediated immune surveillance. Overall, these findings highlight the contribution of oncogenic enhancers in establishing transcriptional memories as an adaptive mechanism to reinforce cancer dormancy and immune escape, thus amenable for therapeutic intervention. Metastasis arises from disseminated tumour cells (DTCs) while the underlying mechanism of DTCs plasticity remains underexplored. Here, the authors show that spatially organized oncogenic enhancers on chromatin sustain the establishment of retinoic acid (RA)-stimulated transcriptional memory through activation of SOX9, supporting the escape of quiescent DTCs from NK-mediated immune surveillance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
33. synNotch-programmed iPSC-derived NK cells usurp TIGIT and CD73 activities for glioblastoma therapy.
- Author
-
Lupo, Kyle B., Yao, Xue, Borde, Shambhavi, Wang, Jiao, Torregrosa-Allen, Sandra, Elzey, Bennett D., Utturkar, Sagar, Lanman, Nadia A., McIntosh, MacKenzie, and Matosevic, Sandro
- Subjects
KILLER cells ,GLIOBLASTOMA multiforme ,TUMOR-infiltrating immune cells ,PURINERGIC receptors ,ANTIBODY formation ,T cells - Abstract
Severe heterogeneity within glioblastoma has spurred the notion that disrupting the interplay between multiple elements on immunosuppression is at the core of meaningful anti-tumor responses. T cell immunoreceptor with Ig and ITIM domains (TIGIT) and its glioblastoma-associated antigen, CD155, form a highly immunosuppressive axis in glioblastoma and other solid tumors, yet targeting of TIGIT, a functionally heterogeneous receptor on tumor-infiltrating immune cells, has largely been ineffective as monotherapy, suggesting that disruption of its inhibitory network might be necessary for measurable responses. It is within this context that we show that the usurpation of the TIGIT − CD155 axis via engineered synNotch-mediated activation of induced pluripotent stem cell-derived natural killer (NK) cells promotes transcription factor-mediated activation of a downstream signaling cascade that results in the controlled, localized blockade of CD73 to disrupt purinergic activity otherwise resulting in the production and accumulation of immunosuppressive extracellular adenosine. Such "decoy" receptor engages CD155 binding to TIGIT, but tilts inhibitory TIGIT/CD155 interactions toward activation via downstream synNotch signaling. Usurping activities of TIGIT and CD73 promotes the function of adoptively transferred NK cells into intracranial patient-derived models of glioblastoma and enhances their natural cytolytic functions against this tumor to result in complete tumor eradication. In addition, targeting both receptors, in turn, reprograms the glioblastoma microenvironment via the recruitment of T cells and the downregulation of M2 macrophages. This study demonstrates that TIGIT/CD155 and CD73 are targetable receptor partners in glioblastoma. Our data show that synNotch-engineered pluripotent stem cell-derived NK cells are not only effective mediators of anti-glioblastoma responses within the setting of CD73 and TIGIT/CD155 co-targeting, but represent a powerful allogeneic treatment option for this tumor. Given its immunosuppressive effect in glioblastoma (GBM), targeting the TIGIT-CD155 axis presents an attractive therapeutic strategy. Here, the authors develop an adoptive natural killer (iNK) cells therapy with anti-CD155 synNotch-inducible CD73 antibody production to reverse the effect of TIGIT-CD155 signaling for the treatment of GBM. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
34. Predictive potentials of glycosylation-related genes in glioma prognosis and their correlation with immune infiltration.
- Author
-
Sun, Yi-Fei, Zhang, Lan-Chun, Niu, Rui-Ze, Chen, Li, Xia, Qing-Jie, Xiong, Liu-Lin, and Wang, Ting-Hua
- Subjects
GLIOMAS ,REGULATORY T cells ,KILLER cells ,ONE-way analysis of variance ,DISEASE risk factors ,PRINCIPAL components analysis ,PROGRESSION-free survival - Abstract
Glycosylation is currently considered to be an important hallmark of cancer. However, the characterization of glycosylation-related gene sets has not been comprehensively analyzed in glioma, and the relationship between glycosylation-related genes and glioma prognosis has not been elucidated. Here, we firstly found that the glycosylation-related differentially expressed genes in glioma patients were engaged in biological functions related to glioma progression revealed by enrichment analysis. Then seven glycosylation genes (BGN, C1GALT1C1L, GALNT13, SDC1, SERPINA1, SPTBN5 and TUBA1C) associated with glioma prognosis were screened out by consensus clustering, principal component analysis, Lasso regression, and univariate and multivariate Cox regression analysis using the TCGA-GTEx database. A glycosylation-related prognostic signature was developed and validated using CGGA database data with significantly accurate prediction on glioma prognosis, which showed better capacity to predict the prognosis of glioma patients than clinicopathological factors do. GSEA enrichment analysis based on the risk score further revealed that patients in the high-risk group were involved in immune-related pathways such as cytokine signaling, inflammatory responses, and immune regulation, as well as glycan synthesis and metabolic function. Immuno-correlation analysis revealed that a variety of immune cell infiltrations, such as Macrophage, activated dendritic cell, Regulatory T cell (Treg), and Natural killer cell, were increased in the high-risk group. Moreover, functional experiments were performed to evaluate the roles of risk genes in the cell viability and cell number of glioma U87 and U251 cells, which demonstrated that silencing BGN, SDC1, SERPINA1, TUBA1C, C1GALT1C1L and SPTBN5 could inhibit the growth and viability of glioma cells. These findings strengthened the prognostic potentials of our predictive signature in glioma. In conclusion, this prognostic model composed of 7 glycosylation-related genes distinguishes well the high-risk glioma patients, which might potentially serve as caner biomarkers for disease diagnosis and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
35. Epigenetic regulation of CD38/CD48 by KDM6A mediates NK cell response in multiple myeloma.
- Author
-
Liu, Jiye, Xing, Lijie, Li, Jiang, Wen, Kenneth, Liu, Ning, Liu, Yuntong, Wu, Gongwei, Wang, Su, Ogiya, Daisuke, Song, Tian-Yu, Kurata, Keiji, Penailillo, Johany, Morelli, Eugenio, Wang, Tingjian, Hong, Xiaoning, Gulla, Annamaria, Tai, Yu-Tzu, Munshi, Nikhil, Richardson, Paul, and Carrasco, Ruben
- Subjects
KILLER cells ,ANTIBODY-dependent cell cytotoxicity ,MULTIPLE myeloma ,DARATUMUMAB ,MONOCLONAL antibodies - Abstract
Anti-CD38 monoclonal antibodies like Daratumumab (Dara) are effective in multiple myeloma (MM); however, drug resistance ultimately occurs and the mechanisms behind this are poorly understood. Here, we identify, via two in vitro genome-wide CRISPR screens probing Daratumumab resistance, KDM6A as an important regulator of sensitivity to Daratumumab-mediated antibody-dependent cellular cytotoxicity (ADCC). Loss of KDM6A leads to increased levels of H3K27me3 on the promoter of CD38, resulting in a marked downregulation in CD38 expression, which may cause resistance to Daratumumab-mediated ADCC. Re-introducing CD38 does not reverse Daratumumab-mediated ADCC fully, which suggests that additional KDM6A targets, including CD48 which is also downregulated upon KDM6A loss, contribute to Daratumumab-mediated ADCC. Inhibition of H3K27me3 with an EZH2 inhibitor resulted in CD38 and CD48 upregulation and restored sensitivity to Daratumumab. These findings suggest KDM6A loss as a mechanism of Daratumumab resistance and lay down the proof of principle for the therapeutic application of EZH2 inhibitors, one of which is already FDA-approved, in improving MM responsiveness to Daratumumab. The anti-CD38 monoclonal antibody Daratumumab is approved for the treatment of multiple myeloma but efficiency is curtailed by secondary resistance. Here authors show that the antibody-dependent cellular cytotoxicity, which is the main mechanism of action for Daratumumab, is regulated by KDM6A via Histone H3 K27 methylation of CD38 and CD48, downregulation of which leads to drug resistance. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
36. TGF-β blockade drives a transitional effector phenotype in T cells reversing SIV latency and decreasing SIV reservoirs in vivo.
- Author
-
Kim, Jinhee, Bose, Deepanwita, Araínga, Mariluz, Haque, Muhammad R., Fennessey, Christine M., Caddell, Rachel A., Thomas, Yanique, Ferrell, Douglas E., Ali, Syed, Grody, Emanuelle, Goyal, Yogesh, Cicala, Claudia, Arthos, James, Keele, Brandon F., Vaccari, Monica, Lorenzo-Redondo, Ramon, Hope, Thomas J., Villinger, Francois, and Martinelli, Elena
- Subjects
T cells ,KILLER cells ,PHENOTYPES ,CELL physiology ,VIRUS reactivation ,VIRAL load ,T cell receptors - Abstract
HIV-1 persistence during ART is due to the establishment of long-lived viral reservoirs in resting immune cells. Using an NHP model of barcoded SIVmac239 intravenous infection and therapeutic dosing of anti-TGFBR1 inhibitor galunisertib (LY2157299), we confirm the latency reversal properties of in vivo TGF-β blockade, decrease viral reservoirs and stimulate immune responses. Treatment of eight female, SIV-infected macaques on ART with four 2-weeks cycles of galunisertib leads to viral reactivation as indicated by plasma viral load and immunoPET/CT with a
64 Cu-DOTA-F(ab')2 -p7D3-probe. Post-galunisertib, lymph nodes, gut and PBMC exhibit lower cell-associated (CA-)SIV DNA and lower intact pro-virus (PBMC). Galunisertib does not lead to systemic increase in inflammatory cytokines. High-dimensional cytometry, bulk, and single-cell (sc)RNAseq reveal a galunisertib-driven shift toward an effector phenotype in T and NK cells characterized by a progressive downregulation in TCF1. In summary, we demonstrate that galunisertib, a clinical stage TGF-β inhibitor, reverses SIV latency and decreases SIV reservoirs by driving T cells toward an effector phenotype, enhancing immune responses in vivo in absence of toxicity. Treatment with the clinical stage TGF-β inhibitor galunisertib promotes latency reversal of HIV/SIV. Here, using a treatment regimen similar to the one tested in clinical trials, the authors show how galunisertib affects immune cell function, increases SIV reactivation, and reduces the viral reservoir in macaques. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
37. Immune checkpoints HLA-E:CD94-NKG2A and HLA-C:KIR2DL1 complementarily shield circulating tumor cells from NK-mediated immune surveillance.
- Author
-
Liu, Xiaowei, Zuo, Fengli, Song, Jinen, Tang, Leyi, Wang, Xueyan, Liu, Xinyu, Zhang, Hao, Yang, Zhankun, Jing, Jing, Ma, Xuelei, and Shi, Hubing
- Subjects
IMMUNE checkpoint proteins ,KILLER cells ,PROBABILITY density function - Abstract
A recent study published in Cell Discovery explores the role of immune checkpoints in preventing tumor metastasis. The researchers found that circulating tumor cells (CTCs) evade immune surveillance by engaging immune checkpoints called HLA-E:CD94-NKG2A, HLA-C:KIR2DL1, and HLA-C:KIR2DL3. Blocking these checkpoints effectively prevents tumor metastasis. The study suggests that targeting these immune checkpoints may be an effective strategy for preventing tumor metastasis in pancreatic ductal adenocarcinoma (PDAC) patients. The findings provide potential strategies for improving the elimination of CTCs by combining the disruption of multiple immune checkpoints. [Extracted from the article]
- Published
- 2024
- Full Text
- View/download PDF
38. Heat shock protein gp96 drives natural killer cell maturation and anti-tumor immunity by counteracting Trim28 to stabilize Eomes.
- Author
-
Xu, Yuxiu, Li, Xin, Cheng, Fang, Zhao, Bao, Fang, Min, Li, Zihai, and Meng, Songdong
- Subjects
HEAT shock proteins ,KILLER cells ,UBIQUITINATION ,GLUCOSE-regulated proteins ,CELL physiology ,IMMUNITY - Abstract
The maturation process of natural killer (NK) cells, which is regulated by multiple transcription factors, determines their functionality, but few checkpoints specifically targeting this process have been thoroughly studied. Here we show that NK-specific deficiency of glucose-regulated protein 94 (gp96) leads to decreased maturation of NK cells in mice. These gp96-deficient NK cells exhibit undermined activation, cytotoxicity and IFN-γ production upon stimulation, as well as weakened responses to IL-15 for NK cell maturation, in vitro. In vivo, NK-specific gp96-deficient mice show increased tumor growth. Mechanistically, we identify Eomes as the downstream transcription factor, with gp96 binding to Trim28 to prevent Trim28-mediated ubiquitination and degradation of Eomes. Our study thus suggests the gp96-Trim28-Eomes axis to be an important regulator for NK cell maturation and cancer surveillance in mice. Natural killer (NK) cell maturation and function are regulated by multiple transcription factors (TF), but detailed molecular insights are scarce. Here the authors show that a TF, Eomes, is important for NK cell responses and cancer surveillance, in which Eomes expression is regulated by gp96 and Trim28 via the ubiquitination and degradation pathways. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
39. A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome.
- Author
-
Hammond, Terese C., Purbhoo, Marco A., Kadel, Sapana, Ritz, Jerome, Nikiforow, Sarah, Daley, Heather, Shaw, Kit, van Besien, Koen, Gomez-Arteaga, Alexandra, Stevens, Don, Ortuzar, Waldo, Michelet, Xavier, Smith, Rachel, Moskowitz, Darrian, Masakayan, Reed, Yigit, Burcu, Boi, Shannon, Soh, Kah Teong, Chamberland, John, and Song, Xin
- Subjects
ADULT respiratory distress syndrome ,CYTOTOXIC T cells ,KILLER cells ,T cells ,T cell receptors ,CELLULAR therapy ,CLINICAL trials ,EXTRACORPOREAL membrane oxygenation - Abstract
Invariant natural killer T (iNKT) cells, a unique T cell population, lend themselves for use as adoptive therapy due to diverse roles in orchestrating immune responses. Originally developed for use in cancer, agenT-797 is a donor-unrestricted allogeneic ex vivo expanded iNKT cell therapy. We conducted an open-label study in virally induced acute respiratory distress syndrome (ARDS) caused by the severe acute respiratory syndrome-2 virus (trial registration NCT04582201). Here we show that agenT-797 rescues exhausted T cells and rapidly activates both innate and adaptive immunity. In 21 ventilated patients including 5 individuals receiving veno-venous extracorporeal membrane oxygenation (VV-ECMO), there are no dose-limiting toxicities. We observe an anti-inflammatory systemic cytokine response and infused iNKT cells are persistent during follow-up, inducing only transient donor-specific antibodies. Clinical signals of associated survival and prevention of secondary infections are evident. Cellular therapy using off-the-shelf iNKT cells is safe, can be rapidly scaled and is associated with an anti-inflammatory response. The safety and therapeutic potential of iNKT cells across diseases including infections and cancer, warrants randomized-controlled trials. Invariant natural killer T (iNKT) cells recognize abnormal cells, but their T cell receptor is not variable and kill cancerous or infected target cells without MHC I restriction. Here, the authors show that in a clinical trial, donor-unrestricted allogeneic iNKT cells could be safely administered to human COVID-19 patients suffering from acute respiratory distress syndrome and trigger an anti-inflammatory response. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
40. Gestational diabetes augments group B Streptococcus infection by disrupting maternal immunity and the vaginal microbiota.
- Author
-
Mercado-Evans, Vicki, Mejia, Marlyd E., Zulk, Jacob J., Ottinger, Samantha, Hameed, Zainab A., Serchejian, Camille, Marunde, Madelynn G., Robertson, Clare M., Ballard, Mallory B., Ruano, Simone H., Korotkova, Natalia, Flores, Anthony R., Pennington, Kathleen A., and Patras, Kathryn A.
- Subjects
STREPTOCOCCUS agalactiae ,STREPTOCOCCAL diseases ,MATERNALLY acquired immunity ,GENITALIA ,GESTATIONAL diabetes ,KILLER cells - Abstract
Group B Streptococcus (GBS) is a pervasive perinatal pathogen, yet factors driving GBS dissemination in utero are poorly defined. Gestational diabetes mellitus (GDM), a complication marked by dysregulated immunity and maternal microbial dysbiosis, increases risk for GBS perinatal disease. Using a murine GDM model of GBS colonization and perinatal transmission, we find that GDM mice display greater GBS in utero dissemination and subsequently worse neonatal outcomes. Dual-RNA sequencing reveals differential GBS adaptation to the GDM reproductive tract, including a putative glycosyltransferase (yfhO), and altered host responses. GDM immune disruptions include reduced uterine natural killer cell activation, impaired recruitment to placentae, and altered maternofetal cytokines. Lastly, we observe distinct vaginal microbial taxa associated with GDM status and GBS invasive disease status. Here, we show a model of GBS dissemination in GDM hosts that recapitulates several clinical aspects and identifies multiple host and bacterial drivers of GBS perinatal disease. Here, Marcado-Evans et al show that gestational diabetes enhances group B Streptococcus infection through altering host-microbe dynamics, disrupting maternal immunity, and perturbing the vaginal microbiota in a murine pregnancy model. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
41. Resistance to cytotoxicity and sustained release of interleukin-6 and interleukin-8 in the presence of decreased interferon-γ after differentiation of glioblastoma by human natural killer cells.
- Author
-
Kozlowska, Anna, Tseng, Han-Ching, Kaur, Kawaljit, Topchyan, Paytsar, Inagaki, Akihito, Bui, Vickie, Kasahara, Noriyuki, Cacalano, Nicholas, and Jewett, Anahid
- Subjects
GLIOBLASTOMA multiforme treatment ,CANCER cell differentiation ,KILLER cells ,INTERLEUKINS ,TUMOR growth ,TUMOR microenvironment ,CELL-mediated cytotoxicity - Abstract
Natural killer (NK) cells are functionally suppressed in the glioblastoma multiforme (GBM) tumor microenvironment. We have recently shown that survival and differentiation of cancer stem-like cells (CSCs)/poorly differentiated tumors are controlled through two distinct phenotypes of cytotoxic and non-cytotoxic/split anergized NK cells, respectively. In this paper, we studied the function of NK cells against brain CSCs/poorly differentiated GBM and their NK cell-differentiated counterparts. Brain CSCs/poorly differentiated GBM, differentiated by split anergized NK supernatants (supernatants from NK cells treated with IL-2 + anti-CD16mAb) expressed higher levels of CD54, B7H1 and MHC-I and were killed less by the NK cells, whereas their CSCs/poorly differentiated counterparts were highly susceptible to NK cell lysis. Resistance to NK cells and differentiation of brain CSCs/poorly differentiated GBM by split anergized NK cells were mediated by interferon (IFN)-γ and tumor necrosis factor (TNF)-α. Brain CSCs/poorly differentiated GBM expressed low levels of TNFRs and IFN-γRs, and when differentiated and cultured with IL-2-treated NK cells, they induced increased secretion of pro-inflammatory cytokine interleukin (IL)-6 and chemokine IL-8 in the presence of decreased IFN-γ secretion. NK-induced differentiation of brain CSCs/poorly differentiated GBM cells was independent of the function of IL-6 and/or IL-8. The inability of NK cells to lyse GBM tumors and the presence of a sustained release of pro-inflammatory cytokines IL-6 and chemokine IL-8 in the presence of a decreased IFN-γ secretion may lead to the inadequacy of NK cells to differentiate GBM CSCs/poorly differentiated tumors, thus failing to control tumor growth. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
42. Metabolic changes of Interleukin-12/15/18-stimulated human NK cells.
- Author
-
Terrén, Iñigo, Orrantia, Ane, Mosteiro, Alba, Vitallé, Joana, Zenarruzabeitia, Olatz, and Borrego, Francisco
- Subjects
- *
CANCER immunotherapy , *KILLER cells , *CYTOKINES , *IMMUNOTHERAPY , *METABOLISM - Abstract
Natural Killer (NK) cells acquire memory-like properties following a brief stimulation with IL-12, IL-15 and IL-18. These IL-12/15/18-preactivated NK cells, also known as cytokine-induced memory-like (CIML) NK cells, have been revealed as a powerful tool in cancer immunotherapy due to their persistence in the host and their increased effector functions. Several studies have shown that NK cells modulate their metabolism in response to cytokine-stimulation and other stimuli, suggesting that there is a link between metabolism and cellular functions. In this paper, we have analyzed metabolic changes associated to IL-12/15/18-stimulation and the relevance of glycolytic pathway for NK cell effector functions. We have found CIML NK cells are able to retain a metabolic profile shifted towards glycolysis seven days after cytokine withdrawal. Furthermore, we found that treatment with 2-DG differently affects distinct NK cell effector functions and is stimuli-dependent. These findings may have implications in the design of NK cell-based cancer immunotherapies. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
43. More things in heaven and earth: defining innate and adaptive immunity.
- Author
-
Biron, Christine A
- Subjects
NATURAL immunity ,KILLER cells ,VIRUS diseases ,IMMUNOLOGY ,GERM cells ,LYMPHOCYTES ,IMMUNE response ,HISTOCOMPATIBILITY - Published
- 2010
- Full Text
- View/download PDF
44. On the Maximum Value of a Cell in a Specified Set of Cells for the Nonhomogeneous Generalized Allocation Scheme.
- Author
-
Chickrin, D.E., Chuprunov, A.N., and Kokunin, P.A.
- Subjects
KILLER cells ,CELLS ,STATIC random access memory - Abstract
For nonhomogeneous generalized allocation schemes we formulate conditions under which the maximum value of a cell of the first K cells converges to a distribution concentrated in two points. The limit distribution is described. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
45. Gaussian Limit Theorems for the Number of Given Value Cells in the Non-Homogeneous Generalized Allocation Scheme.
- Author
-
Chickrin, D. E., Chuprunov, A. N., and Kokunin, P. A.
- Subjects
LIMIT theorems ,FALSE positive error ,KILLER cells ,RANDOM variables ,CELLS - Abstract
In some non-homogeneous generalized allocation schemes we formulate conditions under which the number of given value cells from the first K cells converges to a Gaussian random variable. This result is applied to the study of the type I error and the type II error for analogs of the empty boxes test. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
46. Generation and optimization of off-the-shelf immunotherapeutics targeting TCR-Vβ2+ T cell malignancy.
- Author
-
Ren, Jingjing, Liao, Xiaofeng, Lewis, Julia M., Chang, Jungsoo, Qu, Rihao, Carlson, Kacie R., Foss, Francine, and Girardi, Michael
- Subjects
T cells ,ANTIBODY-dependent cell cytotoxicity ,T cell receptors ,CANCER cells ,CHIMERIC antigen receptors ,KILLER cells ,DISEASE relapse - Abstract
Current treatments for T cell malignancies encounter issues of disease relapse and off-target toxicity. Using T cell receptor (TCR)Vβ2 as a model, here we demonstrate the rapid generation of an off-the-shelf allogeneic chimeric antigen receptor (CAR)-T platform targeting the clone-specific TCR Vβ chain for malignant T cell killing while limiting normal cell destruction. Healthy donor T cells undergo CRISPR-induced TRAC, B2M and CIITA knockout to eliminate T cell-dependent graft-versus-host and host-versus-graft reactivity. Second generation 4-1BB/CD3zeta CAR containing high affinity humanized anti-Vβ scFv is expressed efficiently on donor T cells via both lentivirus and adeno-associated virus transduction with limited detectable pre-existing immunoreactivity. Our optimized CAR-T cells demonstrate specific and persistent killing of Vβ2+ Jurkat cells and Vβ2+ patient derived malignant T cells, in vitro and in vivo, without affecting normal T cells. In parallel, we generate humanized anti-Vβ2 antibody with enhanced antibody-dependent cellular cytotoxicity (ADCC) by Fc-engineering for NK cell ADCC therapy. Clonal Vb2 usage is common among patients with mature T cell lymphoma. Here the authors report the generation of allogeneic CAR-T cells selectively targeting TCR Vb2+ on malignant T cells, with limited normal T cell destruction. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
47. Immune and stromal transcriptional patterns that influence the outcome of classic Hodgkin lymphoma.
- Author
-
Menéndez, Victoria, Solórzano, José L., García-Cosío, Mónica, Alonso-Alonso, Ruth, Rodríguez, Marta, Cereceda, Laura, Fernández, Sara, Díaz, Eva, Montalbán, Carlos, Estévez, Mónica, Piris, Miguel A., and García, Juan F.
- Subjects
HODGKIN'S disease ,T cell receptors ,MYELOID-derived suppressor cells ,CYTOTOXIC T cells ,SUPPRESSOR cells ,CELL populations ,MYELOID cells ,KILLER cells - Abstract
Classic Hodgkin lymphoma (cHL) is characterized by a rich immune microenvironment as the main tumor component. It involves a broad range of cell populations, which are largely unexplored, even though they are known to be essential for growth and survival of Hodgkin and Reed–Sternberg cells. We profiled the gene expression of 25 FFPE cHL samples using NanoString technology and resolved their microenvironment compositions using cell-deconvolution tools, thereby generating patient-specific signatures. The results confirm individual immune fingerprints and recognize multiple clusters enriched in refractory patients, highlighting the relevance of: (1) the composition of immune cells and their functional status, including myeloid cell populations (M1-like, M2-like, plasmacytoid dendritic cells, myeloid-derived suppressor cells, etc.), CD4-positive T cells (exhausted, regulatory, Th17, etc.), cytotoxic CD8 T and natural killer cells; (2) the balance between inflammatory signatures (such as IL6, TNF, IFN-γ/TGF-β) and MHC-I/MHC-II molecules; and (3) several cells, pathways and genes related to the stroma and extracellular matrix remodeling. A validation model combining relevant immune and stromal signatures identifies patients with unfavorable outcomes, producing the same results in an independent cHL series. Our results reveal the heterogeneity of immune responses among patients, confirm previous findings, and identify new functional phenotypes of prognostic and predictive utility. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
48. Structural basis for the activity and specificity of the immune checkpoint inhibitor lirilumab.
- Author
-
Lorig-Roach, Nicholas, Harpell, Nina M., and DuBois, Rebecca M.
- Subjects
IMMUNE checkpoint inhibitors ,PROGRAMMED cell death 1 receptors ,KILLER cells ,IMMUNE system ,ANTINEOPLASTIC agents ,AMINO acids - Abstract
The clinical success of immune checkpoint inhibitors has underscored the key role of the immune system in controlling cancer. Current FDA-approved immune checkpoint inhibitors target the regulatory receptor pathways of cytotoxic T-cells to enhance their anticancer responses. Despite an abundance of evidence that natural killer (NK) cells can also mediate potent anticancer activities, there are no FDA-approved inhibitors targeting NK cell specific checkpoint pathways. Lirilumab, the most clinically advanced NK cell checkpoint inhibitor, targets inhibitory killer immunoglobulin-like receptors (KIRs), however it has yet to conclusively demonstrate clinical efficacy. Here we describe the crystal structure of lirilumab in complex with the inhibitory KIR2DL3, revealing the precise epitope of lirilumab and the molecular mechanisms underlying KIR checkpoint blockade. Notably, the epitope includes several key amino acids that vary across the human population, and binding studies demonstrate the importance of these amino acids for lirilumab binding. These studies reveal how KIR variations in patients could influence the clinical efficacy of lirilumab and reveal general concepts for the development of immune checkpoint inhibitors targeting NK cells. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
49. Unique adipose tissue invariant natural killer T cell subpopulations control adipocyte turnover in mice.
- Author
-
Han, Sang Mun, Park, Eun Seo, Park, Jeu, Nahmgoong, Hahn, Choi, Yoon Ha, Oh, Jiyoung, Yim, Kyung Min, Lee, Won Taek, Lee, Yun Kyung, Jeon, Yong Geun, Shin, Kyung Cheul, Huh, Jin Young, Choi, Sung Hee, Park, Jiyoung, Kim, Jong Kyoung, and Kim, Jae Bum
- Subjects
KILLER cells ,ADIPOSE tissues ,CYTOTOXIC T cells ,ADIPOSE tissue physiology ,FAT cells ,CELL physiology ,ADIPOGENESIS ,STEM cells ,HOMEOSTASIS - Abstract
Adipose tissue invariant natural killer T (iNKT) cells are a crucial cell type for adipose tissue homeostasis in obese animals. However, heterogeneity of adipose iNKT cells and their function in adipocyte turnover are not thoroughly understood. Here, we investigate transcriptional heterogeneity in adipose iNKT cells and their hierarchy using single-cell RNA sequencing in lean and obese mice. We report that distinct subpopulations of adipose iNKT cells modulate adipose tissue homeostasis through adipocyte death and birth. We identify KLRG1
+ iNKT cells as a unique iNKT cell subpopulation in adipose tissue. Adoptive transfer experiments showed that KLRG1+ iNKT cells are selectively generated within adipose tissue microenvironment and differentiate into a CX3CR1+ cytotoxic subpopulation in obese mice. In addition, CX3CR1+ iNKT cells specifically kill enlarged and inflamed adipocytes and recruit macrophages through CCL5. Furthermore, adipose iNKT17 cells have the potential to secrete AREG, and AREG is involved in stimulating adipose stem cell proliferation. Collectively, our data suggest that each adipose iNKT cell subpopulation plays key roles in the control of adipocyte turnover via interaction with adipocytes, adipose stem cells, and macrophages in adipose tissue. Invariant natural killer T (iNKT) cells have recently been reported to play a key role in adipose tissue homeostasis. Here, the authors show that adipose tissue iNKT cells mediate immune responses that control adipocyte turnover in mice. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
50. Hyperactive Natural Killer cells in Rag2 knockout mice inhibit the development of acute myeloid leukemia.
- Author
-
Sugimoto, Emi, Li, Jingmei, Hayashi, Yasutaka, Iida, Kohei, Asada, Shuhei, Fukushima, Tsuyoshi, Tamura, Moe, Shikata, Shiori, Zhang, Wenyu, Yamamoto, Keita, Kawabata, Kimihito Cojin, Kawase, Tatsuya, Saito, Takeshi, Yoshida, Taku, Yamazaki, Satoshi, Kaito, Yuta, Imai, Yoichi, Denda, Tamami, Ota, Yasunori, and Fukuyama, Tomofusa
- Subjects
ACUTE myeloid leukemia ,KILLER cells ,B cells ,KNOCKOUT mice ,T cells ,LABORATORY mice ,CELLULAR recognition - Abstract
Immunotherapy has attracted considerable attention as a therapeutic strategy for cancers including acute myeloid leukemia (AML). In this study, we found that the development of several aggressive subtypes of AML is slower in Rag2
−/− mice despite the lack of B and T lymphocytes, even compared to the immunologically normal C57BL/6 mice. Furthermore, an orally active p53-activating drug shows stronger antileukemia effect on AML in Rag2−/− mice than C57BL/6 mice. Intriguingly, Natural Killer (NK) cells in Rag2−/− mice are increased in number, highly express activation markers, and show increased cytotoxicity to leukemia cells in a coculture assay. B2m depletion that triggers missing-self recognition of NK cells impairs the growth of AML cells in vivo. In contrast, NK cell depletion accelerates AML progression in Rag2−/− mice. Interestingly, immunogenicity of AML keeps changing during tumor evolution, showing a trend that the aggressive AMLs generate through serial transplantations are susceptible to NK cell-mediated tumor suppression in Rag2−/− mice. Thus, we show the critical role of NK cells in suppressing the development of certain subtypes of AML using Rag2−/− mice, which lack functional lymphocytes but have hyperactive NK cells. Natural Killer (NK) cells play a role in suppressing the development of certain subtypes of acute myeloid leukemia as shown by employing Rag2−/− mice as model system, which lack functional lymphocytes but have hyperactive NK cells. [ABSTRACT FROM AUTHOR]- Published
- 2023
- Full Text
- View/download PDF
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.